Perrigo Company (Israel) Profile

Performance

   

 Odds of Distress 

15%15%
Check how we calculate scores
Equity ratings for Perrigo Company plc are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting March 23, 2019 and ending today May 22, 2019. Click here to learn more.
17,680
ILS 140  0.79%

Perrigo Company Summary

Perrigo Company plc (PRGO) is traded on Tel Aviv Stock Exchange in Israel and employs 10,600 people. The company currently falls under 'Large-Cap' category with current market capitalization of 26.07B. Perrigo Company operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 135.86M outstanding shares. PERRIGO has accumulated about 841.6M in cash with 515.1M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.19.
Check Perrigo Company Probability Of Bankruptcy

Ownership Allocation (%)

Perrigo Company Target Price Odds Analysis

Odds Below 17680.0HorizonTargetOdds Above 17680.0
49.03%30 days 17,680 50.48%
Based on normal probability distribution, the odds of Perrigo Company to move above current price in 30 days from now is about 50.48% (This Perrigo Company plc probability density function shows the probability of Perrigo Company Stock to fall within a particular range of prices over 30 days) .

Perrigo Company Top Holders

Perrigo Company Risk Profiles

Perrigo Company Key Fundamentals

Perrigo Company Against Markets

Perrigo Company Vital Trading Data

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug Manufacturers - Specialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 10600 people. more
NamePerrigo Company plc
President CEO, DirectorUwe RohrhoffView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business AddressThe Sharp Building
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
BenchmarkDOW
Websitewww.perrigo.com
Phone353 1 709 4000
CurrencyILS - Israeli Shekel
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterMarch 30, 2019
Last Fiscal Year EndDecember 31, 2018

Perrigo Company Distributions to stockholders

Perrigo Company Corporate Directors

Gary Cohen Independent Director
Laurie Brlas Independent Director
Donal OConnor Independent Director
Additionally take a look at Your Equity Center. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Search macroaxis.com